Back to search
Non Invasive Prenatal Diagnosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non Invasive Prenatal Diagnosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non Invasive Prenatal Diagnosis trials you may qualify forCell-free fetal DNA (cffDNA) is present in the maternal blood from the early first trimester of gestation and makes up 5%-20% of the total circulating cell-free…
The purpose of this study is to develop the safety, feasibility, and tolerability of a personalized transcranial alternating current stimulation (tACS) approach…
Antenatal nonstress tests (NSTs) are performed to assess fetal health and are used as a cost-effective test that can be widely administered. However, an NST is…
The objective of this single center, interventional cohort study is to evaluate the feasibility of remote electrophysiological cardiotocography (eCTG) monitorin…
A multidisciplinary team of a doctor and engineers have developed a new sensor that will be able to detect mothers' and babies' heartbeat and babies movements i…
The aim of this study is the early (presymptomatic) detection of pregnancy complications, which could contribute to a preventive treatment.
The objective of this project is to develop a non-invasive prenatal diagnostic test for trisomy 21 which is reliable, sensitive and cost-effective, and thus, of…
Since the discovery of a small fraction of circulating cell-free fetal DNA (ccffDNA) in the blood of the mother, non-invasive prenatal diagnosis (NIPD) techniqu…
The purpose of this observational study is to measure pulmonary function in term and preterm infants with and without pulmonary disease including respiratory di…